Registration, Results Reporting, and Publication Bias of Clinical Trials Supporting FDA Approval of Neuropsychiatric Drugs Before and After FDAAA: A Retrospective Cohort Study

Trials - United Kingdom
doi 10.1186/s13063-018-2957-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation

JAMA - Journal of the American Medical Association
Medicine
2018English

Publication Statuses of Clinical Trials Supporting FDA-approved Immune Checkpoint Inhibitors: A Meta-Epidemiological Investigation

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Prospective Registration, Bias Risk and Outcome-Reporting Bias in Randomised Clinical Trials of Traditional Chinese Medicine: An Empirical Methodological Study

BMJ Open
Medicine
2013English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

Fate of Biomedical Research Protocols and Publication Bias in France: Retrospective Cohort Study

BMJ
2005English

Comparison of Outcomes Before and After Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology: A Willingness-To-Participate Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Prospective Registration and Outcome-Reporting Bias in Randomized Controlled Trials of Eczema Treatments: A Systematic Review

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy